Uncategorized

Nader Kabbani, who led the technology giant’s acquisition of PillPack and the launch of Amazon Pharmacy, will take the chief operating officer title at the telehealth firm this month.

The company expects a tariff impact of up to 300 million euros ($339 million), with the biggest hit from European goods going to the U.S.

The biopharma job market likely won’t turn around until 2026, according to two industry experts. Both cited a need for more investment and noted the impact of uncertainty on the industry.

The maker of patient monitoring devices is working to bring the affected portions of its network back online and restore normal business operations.

The cell engineering company, co-founded by oncologist and writer Siddhartha Mukherjee, does not see a path forward for its pipeline of early-stage cell therapies for two different types of cancer.

After more than a month of speculation over how the FDA will rule on Novavax’s application for an updated formulation of its COVID-19 shot, CEO John Jacobs said on the company’s Q1 earnings call: “When we have it, we’ll have it. Until then, we don’t have it.”

In this episode of Denatured BioSpace’s head of insights Lori Ellis discusses the public health consequences of vaccine hesitancy and the critical distinction between skepticism and cynicism with Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.

Takeda’s Julie Kim argues that Trump’s idea to match drug prices to that of other countries could cost the industry up to $1 trillion over the next 10 years.

Se estima que un 13% de los casos mundiales de la enfermedad de Alzheimer pueden atribuirse a la inactividad física. De hecho, la Organización Mundial de la Salud (OMS) recomienda de 150 a 300 minutos de actividad moderada por semana o de 75 a 150 minutos de actividad intensa por seman …

Gilead will construct three new facilities in the U.S., while upgrading three others. The company claims the investment will produce “$43 billion in value.”